Xanomeline
Xanomeline | CAS NO: 174656-58-7, Xanomeline is a muscarinic acetylcholine receptor agonist with a unique profile, primarily targeting M1 and M4 receptor subtypes. It has been investigated for several central nervous system (CNS) conditions, primarily because of its pro-cognitive and antipsychotic potential.
We are the Synchemia Research Chemical specializes in manufacturing and supplying of Xanomeline impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities Use: Treatment of schizophrenia symptoms, particularly positive symptoms (like hallucinations and delusions), as well as negative symptoms and cognitive impairment. Status: Under clinical development; xanomeline-trospium (a combination with the peripheral antagonist trospium to reduce side effects) has shown promise in Phase 3 trials.Buy Reliable and High-Purity Xanomeline Impurities, Delivered by Synchemia Research Chemicals.
Pharmaceutical Reference Standards
| CAT No | SRC-X24105 |
| CAS No | 131986-66-8 |
| Mol.F. | C15H25N3OS |
| Mol.Wt. | 295.17 g/mol |
| INV STATUS | IN STOCK |
| CAT No | SRC-X24106 |
| CAS No | NA |
| Mol.F. | C14H23N3O2S |
| Mol.Wt. | 297.15 g/mol |
| INV STATUS | IN STOCK |
| CAT No | SRC-X24107 |
| CAS No | NA |
| Mol.F. | C28H46N6O2S2 |
| Mol.Wt. | 562.8 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-X24108 |
| CAS No | NA |
| Mol.F. | C15H21N3O5S |
| Mol.Wt. | 355.41 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-X24109 |
| CAS No | NA |
| Mol.F. | C28H44N6O2S2 |
| Mol.Wt. | 560.8 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-X24110 |
| CAS No | 131987-88-7 |
| Mol.F. | C7H5N3S |
| Mol.Wt. | 163.2 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-X24111 |
| CAS No | 748751-53-3 |
| Mol.F. | C15H26N3OS |
| Mol.Wt. | 296.5 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-X24112 |
| CAS No | 131986-59-9 |
| Mol.F. | C8H10ClN3S |
| Mol.Wt. | 215.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-X24113 |
| CAS No | NA |
| Mol.F. | C13H21N3OS |
| Mol.Wt. | 267.39 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Let’s advance your research together.
Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.